GRNCM-1

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGRNCM-1
Drug Alias Namestem cell-derived cardiomyocytes (Geron)stem cell-derived cardiomyocytes (Asterias)GRNCM-1
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Cardiac myocyte stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHeart Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeron Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsterias Biotherapeutics IncGeron Corp
Active IndicationsN/A
Inactive IndicationsHeart Diseases

Other Information

ATC CodeN/A
Related LinksN/A